Giannetti, A. B.; Soares, R. B. S.; Costanzi-Strauss, Eugenia 
; Strauss, B. E.
Source: Applied Cancer Research - Supplement. Conference titles: Research Conference Cancer Today: From Molecular Biology to Treatment. Unidade: ICB
Assunto: HISTOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIANNETTI, A. B. et al. Strategic combination of pCLPG-mediated transfer of the p53 and p19ARF tumor suppressors for gene therapy of melanoma. Applied Cancer Research - Supplement. Ribeirão Preto: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 01 out. 2024. , 2005APA
Giannetti, A. B., Soares, R. B. S., Costanzi-Strauss, E., & Strauss, B. E. (2005). Strategic combination of pCLPG-mediated transfer of the p53 and p19ARF tumor suppressors for gene therapy of melanoma. Applied Cancer Research - Supplement. Ribeirão Preto: Instituto de Ciências Biomédicas, Universidade de São Paulo.NLM
Giannetti AB, Soares RBS, Costanzi-Strauss E, Strauss BE. Strategic combination of pCLPG-mediated transfer of the p53 and p19ARF tumor suppressors for gene therapy of melanoma. Applied Cancer Research - Supplement. 2005 ;( 2): 51 res. P038.[citado 2024 out. 01 ]Vancouver
Giannetti AB, Soares RBS, Costanzi-Strauss E, Strauss BE. Strategic combination of pCLPG-mediated transfer of the p53 and p19ARF tumor suppressors for gene therapy of melanoma. Applied Cancer Research - Supplement. 2005 ;( 2): 51 res. P038.[citado 2024 out. 01 ]
